Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director departure
|
|
JANUS HENDERSON GROUP PLC (JHG)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 10.1% stake in SOLENO THERAPEUTICS, INC. |
| 08/18/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/18/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/10/2023 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 12.3% stake in AVADEL PHARMACEUTICALS PLC |
| 07/05/2023 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 5.1% stake in AN2 Therapeutics, Inc. |
| 05/25/2023 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 5.1% stake in Bellerophon Therapeutics, Inc. |
| 02/14/2023 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 8.3% stake in 89bio, Inc. |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/01/2023 |
SC 13G
| BlackRock Inc. reports a 11.3% stake in JANUS HENDERSON GROUP PLC |
| 01/31/2023 |
SC 13G
| Silchester International Investors LLP reports a 8.5% stake in Janus Henderson Group plc |
| 12/21/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 6% stake in Mirion Technologies, Inc. |
| 02/14/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 5.7% stake in Aligos Therapeutics, Inc. |
| 02/11/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 5.8% stake in Janux Therapeutics, Inc. |
| 02/11/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 5.1% stake in HOSTESS BRANDS, INC. |
| 02/11/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 6.1% stake in Redfin Corporation |
| 02/11/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 7.1% stake in Rush Street Interactive, Inc. |
| 02/11/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 7.4% stake in MSD Acquisition Corp. |
| 02/11/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 7.5% stake in PRAXIS PRECISION MEDICINES, INC. |
| 02/11/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 5.7% stake in Aligos Therapeutics, Inc. |
| 02/11/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 5.3% stake in Cyteir Therapeutics, Inc. |
| 02/11/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 5.1% stake in YEXT, INC. |
| 02/11/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 5.1% stake in 4D Molecular Therapeutics, Inc. |
| 02/11/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 5.3% stake in VROOM, INC. |
| 02/11/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 5.5% stake in Seres Therapeutics, Inc. |
| 02/11/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 5.5% stake in PTC Therapeutics, Inc. |
| 02/11/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/11/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/11/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 6.4% stake in CENTESSA PHARMACEUTICALS PLC |
|
|
|